ERK activation was also delayed in the presence of 1 μM atrazine compared with 100 nM E2 in 2008 ovarian cancer cells (Figure 6D), which present a receptor expression similar to that of BG-1 cells (Safei et al. 2005). Here, MAPK1 is linked to ovarian carcinoma.